Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M VAUGHAN

Showing results (11-20 of 867) with videos related to

Pageof 87
Sort By:
European Heart Journal|November 1, 1985
Delayed ventricular repolarization as an anti-arrhythmic principleE M Vaughan Williams
Journal of Clinical Pharmacology|February 1, 1987
Is phosphodiesterase inhibition arrhythmogenic? Electrophysiologic effects in pithed rats and in normoxic and hypoxic rabbit atria of enoximone, a new cardiotonic agentE M Vaughan Williams
Journal of Clinical Pharmacology|April 1, 1984
A classification of antiarrhythmic actions reassessed after a decade of new drugsE M Vaughan Williams
Journal of Clinical Pharmacology|February 1, 1991
Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trialE M Vaughan Williams
Journal of Cardiovascular Pharmacology|January 1, 1985
Cardiac electrophysiological effects of selective adrenoceptor stimulation and their possible roles in arrhythmiasE M Vaughan Williams
Journal of Clinical Pharmacology|July 1, 1987
Bevantolol: a beta-1 adrenoceptor antagonist with unique additional actionsE M Vaughan Williams
Journal of Clinical Pharmacology|November 1, 1992
Classifying antiarrhythmic actions: by facts or speculationE M Vaughan Williams
The Journal of Biological Chemistry|April 10, 1977
Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptorJ Moss, M Vaughan
Molecular Microbiology|November 1, 1991
Activation of cholera toxin and Escherichia coli heat-labile enterotoxins by ADP-ribosylation factors, a family of 20 kDa guanine nucleotide-binding proteinsJ Moss, M Vaughan
Journal of Clinical Pharmacology|March 1, 1991
Classification of the antiarrhythmic action of moricizineE M Vaughan Williams
Pageof 87

Showing results (11-20 of 867) with videos related to

Sort By:
Pageof 87
European Heart Journal|November 1, 1985
Delayed ventricular repolarization as an anti-arrhythmic principleE M Vaughan Williams
Journal of Clinical Pharmacology|February 1, 1987
Is phosphodiesterase inhibition arrhythmogenic? Electrophysiologic effects in pithed rats and in normoxic and hypoxic rabbit atria of enoximone, a new cardiotonic agentE M Vaughan Williams
Journal of Clinical Pharmacology|April 1, 1984
A classification of antiarrhythmic actions reassessed after a decade of new drugsE M Vaughan Williams
Journal of Clinical Pharmacology|February 1, 1991
Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trialE M Vaughan Williams
Journal of Cardiovascular Pharmacology|January 1, 1985
Cardiac electrophysiological effects of selective adrenoceptor stimulation and their possible roles in arrhythmiasE M Vaughan Williams
Journal of Clinical Pharmacology|July 1, 1987
Bevantolol: a beta-1 adrenoceptor antagonist with unique additional actionsE M Vaughan Williams
Journal of Clinical Pharmacology|November 1, 1992
Classifying antiarrhythmic actions: by facts or speculationE M Vaughan Williams
The Journal of Biological Chemistry|April 10, 1977
Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptorJ Moss, M Vaughan
Molecular Microbiology|November 1, 1991
Activation of cholera toxin and Escherichia coli heat-labile enterotoxins by ADP-ribosylation factors, a family of 20 kDa guanine nucleotide-binding proteinsJ Moss, M Vaughan
Journal of Clinical Pharmacology|March 1, 1991
Classification of the antiarrhythmic action of moricizineE M Vaughan Williams
Pageof 87